Visão geral da empresa
Visionary Holdings Inc. operates as a provider of educational resources to students globally, while simultaneously engaging in significant ventures within large-scale health and elderly care, anti-aging treatments, high-end medical aesthetics, and artificial intelligence education services. The enterprise functions within the Consumer Defensive sector, specifically categorized under the Education & Training Services industry, positioning it as a potential hedge against economic downturns through its diverse service portfolio. This company employs a workforce of 64 individuals to support its operations across these varied sectors, including its involvement in large health projects and anti-aging initiatives. The current market capitalization stands at $1.70M, supported by annual revenue of $5.04M, which indicates a micro-cap status with limited operational scale relative to its stated ambitions in high-end medical and education markets. The combination of a small employee base with a diverse revenue stream from health, education, and AI services suggests a business model attempting to leverage multiple growth vectors while maintaining a modest physical footprint.
Saúde financeira
The company reported revenue of $5.04M for the trailing twelve months, yet generated a net income of $-15,842,407, revealing a severe disconnect where operating expenses or one-time charges vastly outweighed all revenue generated. This substantial gap between revenue and net income indicates a cost structure that is currently unsustainable, as the firm loses over fifteen million dollars despite collecting five million in sales. EBITDA stands at $-1,346,134, showing that even before interest, taxes, depreciation, and amortization, the core business operations are generating negative cash earnings. Free cash flow is recorded at $-520,235, which implies that the company is burning cash on an ongoing basis and possesses no financial flexibility to fund organic growth or weather market shocks without external capital injection. While the firm holds cash of $334,910, this liquid asset is significantly overshadowed by total debt of $48.58M, creating a precarious balance sheet where liabilities exceed liquid assets by a factor of nearly 146. The debt-to-equity ratio of 934.98 further confirms an extremely leveraged position, suggesting that the company relies heavily on borrowed funds relative to its shareholder equity. Operating margin is reported at -194.4%, indicating that for every dollar of revenue, the company loses nearly two dollars in operations, while profit margin sits at 0.0% and return on equity is -137.3%, signaling that management is not generating returns for shareholders and is actually destroying equity value. The current ratio of 0.07 highlights a critical liquidity shortfall, meaning the company possesses less than one-tenth of the current assets necessary to cover its short-term obligations. Return on assets stands at -2.9%, reinforcing the conclusion that the asset base is failing to generate positive economic value for the firm.
Avaliação de valorização
Trailing P/E and forward P/E ratios are both listed as N/A due to the company's lack of positive earnings, a common characteristic for firms in negative profitability that prevents traditional earnings-based valuation methods from functioning. The price-to-book ratio is 0.33, indicating that the stock is trading at a significant discount to its book value, which often reflects market skepticism regarding the quality of assets or the ability to convert them into cash. Price-to-sales ratio stands at 0.34, suggesting the market values the company's revenue stream at a fraction of its total sales, while the EV/EBITDA multiple of -37.16 underscores the inability to value the firm based on cash flow generation. The 52-week high is $4.18 and the 52-week low is $0.18, meaning the stock has experienced extreme volatility within this trading range over the past year. The beta value is 0.73, indicating that the stock price tends to be less volatile than the broader market, moving with a dampened sensitivity to general market fluctuations. These alternative valuation metrics collectively paint a picture of a deeply undervalued or distressed asset where the market has priced in significant risks related to the company's financial instability and negative cash flow profile.
Growth & Income
Revenue growth year-over-year is -61.7%, while earnings growth is N/A, indicating that the company is actively shrinking its top line and has no positive earnings trajectory to speak of. The contraction in revenue suggests that the business is struggling to retain market share or expand its customer base within the education and health sectors. Since the company is not a dividend payer, the dividend yield and payout ratio are both N/A, meaning the firm reinvests its minimal retained earnings or attempts to service its debt rather than distributing income to shareholders. The overall growth and income profile is characterized by significant revenue contraction and a complete absence of dividend distributions, reflecting a business in a distressed state that prioritizes survival over shareholder returns or organic expansion.